Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/48861
Type
PatentCopyright
Open access
Collections
- PR - ICC - Patentes [32]
Metadata
Show full item record
POLYPEPTIDE WITH ASPARAGINASE ACTIVITY, EXPRESSION CASSETTE, EXPRESSION VECTOR, HOST CELL, PHARMACEUTICAL COMPOSITION, METHODS FOR PRODUCING A POLYPEPTIDE WITH ASPARAGINASE ACTIVITY AND FOR PREVENTING OR TREATING CANCER, AND USE OF A POLYPEPTIDE
Organização Mundial para Propriedade Intelectual OMPI
China
Escritório de Patentes Europeu
Estados Unidos da América
Índia
Canadá
Inventor(s)
Affilliation
Fundação Oswaldo Cruz. Instituto Carlos Chagas. Curitiba, PR, Brasil.
Fundação Oswaldo Cruz. Instituto Carlos Chagas. Curitiba, PR, Brasil.
Fundação Oswaldo Cruz. Instituto Carlos Chagas. Curitiba, PR, Brasil.
Fundação Oswaldo Cruz. Instituto Carlos Chagas. Curitiba, PR, Brasil.
Fundação Oswaldo Cruz. Instituto Carlos Chagas. Curitiba, PR, Brasil.
Applicant
Fundação Oswaldo CruzFilling number
US16/963,173
Filling date
2020-07-17
Priority number
BR102018001033-6A2
Patent number
US2021/0121544A1
Abstract
The present invention refers to polypeptides with asparaginase activity that have an increased rate of self-processing compared to human wild L-asparaginase (ASRGL1), with mutation in the ASRGL1 glycine rich loop called HGG loop (Histidine 8-Glycine 9-Glycine 10). Polynucleotides that encode the polypeptides of invention are also described here, expression cassettes comprising so-called polynucleotides, expression vectors, host cells, pharmaceutical compositions, uses of the invention polypeptide in the manufacture of a preventive medicine or cancer treatment and methods to produce the polypeptide of invention and to prevent or treat cancer.
Publisher
United States Patent and Trademark Office
IPC number
A61K 38/50C12N 15/66A61P 35/02
Filling country
BrasilOrganização Mundial para Propriedade Intelectual OMPI
China
Escritório de Patentes Europeu
Estados Unidos da América
Índia
Canadá
Share